Related Experiment Video
Updated: Jun 26, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Cardiovascular disease in chronic kidney disease
Anita M Saran1, Thomas D DuBose
1Department of Internal Medicine, Section on Nephrology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. asaran@wfubmc.edu
Insights
Kidney disease, including chronic kidney disease (CKD), significantly increases cardiovascular disease (CVD) risk. Early screening and aggressive management of risk factors in CVD patients with CKD are crucial for better outcomes.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Kidney disease, indicated by reduced glomerular filtration rate (GFR) and proteinuria, is an independent risk factor for cardiovascular disease (CVD).
- The risk of CVD and mortality increases with the severity of kidney disease.
- Early detection and management of chronic kidney disease (CKD) are vital for slowing disease progression and reducing proteinuria.
Purpose of the Study:
- To highlight the independent association between kidney disease and increased cardiovascular disease (CVD) risk.
- To recommend early screening and management strategies for CKD in patients with CVD.
- To emphasize the need for further research into non-traditional risk factors and cardiovascular interventions in CKD patients.
Main Methods:
- Screening for CKD in all patients with CVD.
- Calculating estimated glomerular filtration rate (eGFR).
- Evaluating proteinuria using a spot urine albumin-to-creatinine ratio (ACR).
Main Results:
- Kidney disease is independently linked to higher rates of cardiovascular disease (CVD) and mortality.
- Disease severity correlates with increased CVD risk.
- Aggressive management of traditional cardiovascular risk factors is recommended for this high-risk group.
Conclusions:
- CKD requires early recognition and treatment to slow progression and reduce proteinuria.
- Screening for CKD in CVD patients is recommended, including eGFR and ACR assessment.
- Rigorous control of hypertension (ACEI/ARB use), hyperglycemia, hyperlipidemia, and smoking cessation are essential.
Abstract:
The presence of kidney disease, manifested by low glomerular filtration rates (GFR) and/or large amounts of protein in the urine, is independently associated with increased rates of cardiovascular disease (CVD). The severity of kidney disease is associated with graded increases in risk for CVD and death. Chronic kidney disease (CKD) should be recognized and treatment initiated early to maximize the chances for slowing nephropathy progression and reducing proteinuria. We recommend screening for CKD in all patients with CVD, including computing an estimated GFR and evaluating for proteinuria using a spot urine albumin:creatinine ratio. Aggressive management of traditional cardiovascular risk factors should be employed in this high-risk population, specifically rigorous hypertension control (including the use of angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blocking agents (ARB)), management of hyperglycemia, hyperlipidemia and smoking cessation. Further studies are needed to identify the unique renal failure-related (non-traditional) risk factors that contribute to accelerated atherosclerosis in this population and performance of randomized trials to assess the effects of cardiovascular interventions in individuals with CKD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Diabetic Nephropathy
Heart Failure Drugs: Diuretics
